Stage IIIA Cervical Cancer FIGO 2018
Oncology
Prevalence
18.0 / 100K
Incidence
7.5 / 100K/yr
0 drugs in development·0 companies·2 clinical trials
Frequently asked questions
How many clinical trials target Stage IIIA Cervical Cancer FIGO 2018?
There are 2 clinical trials targeting Stage IIIA Cervical Cancer FIGO 2018 tracked by BioSniper.
What is the prevalence of Stage IIIA Cervical Cancer FIGO 2018?
The estimated prevalence of Stage IIIA Cervical Cancer FIGO 2018 is approximately 18.0 per 100,000 population.
Deep-dive into Stage IIIA Cervical Cancer FIGO 2018
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis